And one has to ask ourselves if the Piedmont ' Deal ' as it was has NOT actually been finalized in terms of the ultimate ' Rider clause ' of formally agreeing to a ' Start Date ' for shipment , then why hasn't Piedmont nominated and put forward their otherwise eligible BOD member to protect their interests in Quebec which I presume one of their priorities is to see that Sayona is in fact the most prosperous and economic it can be....
And lets face it , it's been what 9 months almost since the so called Deal was presumed consummated. So clearly its all about LONG TERM trust and mutually prosperity.
Then there is the agreement with I.Q and Quebec which of course superseded and what a prerequisite ' Non Negotiable ' to the NAL acquisition which stated that they will be producing added value Lithium Chemicals by year 6. So that means if Sayona is only starting its spodumene deliveries to Piedmont in year 2 , that leaves only 4 years until Sayona is producing either Carbonate and / or Hydroxides out of their plant. And we know the deal doesn't cover converted Lithium Chemicals does it ?.........
And we also ALL know or should know , that the progression to conversion just doesn't happen overnight and would have at least approximately 2 years lead in time.
So that then leaves Piedmont with only 2 years supply of a LOM agreement where Sayona won't even be producing much spod ( we hope ) . So who would be the silly one here in assuming that Sayona will only ever be producing spod...... Well no one really because Piedmont is clearly invested for the long term and YES - knew as did Brett that longer term prices would be significantly higher , but BOTH men also knew that it wouldn't matter in the longer term scheme of things.
- Forums
- ASX - By Stock
- SYA
- General Discussion Topics
General Discussion Topics, page-21858
-
-
- There are more pages in this discussion • 119,552 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYA (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $349.9M |
Open | High | Low | Value | Volume |
3.4¢ | 3.6¢ | 3.3¢ | $1.369M | 39.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
72 | 25281049 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 2185907 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
71 | 24781049 | 0.033 |
189 | 45743490 | 0.032 |
61 | 11743210 | 0.031 |
105 | 16172427 | 0.030 |
27 | 5292394 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 2185907 | 13 |
0.035 | 3958066 | 13 |
0.036 | 6811520 | 29 |
0.037 | 6675044 | 25 |
0.038 | 4107914 | 19 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SYA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online